D A Sears1, M M Udden, L J Thomas. 1. Department of Medicine, Baylor College of Medicine and Ben Taub General Hospital, Houston, Texas 77030, USA. dsears@bcm.tmc.edu
Abstract
BACKGROUND: When carbon monoxide binds to hemoglobin, it increases the affinity of hemoglobin for oxygen and shifts the oxygen dissociation curve to the left. The resulting decrease in sickling tendency could have clinical benefit, and carbon monoxide has been suggested as a treatment for sickle-cell disease. Furthermore, in sickle-cell disease, as in other hemolytic diseases, endogenous carbon monoxide production is increased because of increased heme catabolism. METHODS: In the present study, we measured carboxyhemoglobin levels in sickle-cell patients and compared them with estimates of the hemolytic and the vasoocclusive severity of the disease. RESULTS: Significant correlation was found between carboxyhemoglobin (HbCO) levels and hematocrit, reticulocyte count, unconjugated bilirubin level, and percentage of irreversibly sickled cells. However, there was no significant correlation between carboxyhemoglobin levels and measures of the vaso-occlusive severity of the disease. CONCLUSIONS: The correlations between HbCO levels and measures of hemolytic severity are best explained by the known relationship between hemoglobin catabolism and CO production. The lack of correlation with vaso-occlusive severity may be due to the complex changes involved and the difficulty of quantifying vasoocclusive severity.
BACKGROUND: When carbon monoxide binds to hemoglobin, it increases the affinity of hemoglobin for oxygen and shifts the oxygen dissociation curve to the left. The resulting decrease in sickling tendency could have clinical benefit, and carbon monoxide has been suggested as a treatment for sickle-cell disease. Furthermore, in sickle-cell disease, as in other hemolytic diseases, endogenous carbon monoxide production is increased because of increased heme catabolism. METHODS: In the present study, we measured carboxyhemoglobin levels in sickle-cell patients and compared them with estimates of the hemolytic and the vasoocclusive severity of the disease. RESULTS: Significant correlation was found between carboxyhemoglobin (HbCO) levels and hematocrit, reticulocyte count, unconjugated bilirubin level, and percentage of irreversibly sickled cells. However, there was no significant correlation between carboxyhemoglobin levels and measures of the vaso-occlusive severity of the disease. CONCLUSIONS: The correlations between HbCO levels and measures of hemolytic severity are best explained by the known relationship between hemoglobin catabolism and CO production. The lack of correlation with vaso-occlusive severity may be due to the complex changes involved and the difficulty of quantifying vasoocclusive severity.
Authors: Jason B Caboot; Abbas F Jawad; Joseph M McDonough; Cheryl Y Bowdre; Raanan Arens; Carole L Marcus; Thornton B A Mason; Kim Smith-Whitley; Kwaku Ohene-Frempong; Julian L Allen Journal: Pediatr Pulmonol Date: 2012-02-10
Authors: Xavier Bemtgen; Jonathan Rilinger; Manuel Holst; Felix Rottmann; Corinna N Lang; Markus Jäckel; Viviane Zotzmann; Christoph Benk; Tobias Wengenmayer; Alexander Supady; Dawid L Staudacher Journal: Diagnostics (Basel) Date: 2022-07-05
Authors: Thomas Hänscheid; Tom Gresnigt; Sascha Löhr; Arnaud Flamen; Thomas Zoller; José Melo-Cristino; Martin P Grobusch Journal: Malar J Date: 2014-07-23 Impact factor: 2.979